EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels

Federica Fogacci iD, Marina Giovannini iD, Antonio Di Micoli, Giulia Fiorini iD, Elisa Grandi, Claudio Borghi iD, Arrigo F G Cicero iD

Nutrients · 23.05.2024 · 16 (11) · 1587

DOI: 10.3390/nu16111587 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 23.05.2024. Verfasst von Federica Fogacci und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hypertension and Cardiovascular Risk Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, 40138 Bologn…. Hauptthemen laut MEDLINE: Cynara scolymus, Dietary Supplements, Plant Extracts, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Meda Pharma S.p.A. (Monza, MB, Italy).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to assess whether dietary supplementation with a nutraceutical blend comprising extracts of bergamot and artichoke—both standardized in their characteristic polyphenolic fractions—could positively affect serum lipid concentration and insulin sensitivity, high-sensitivity C-reactive protein (hs-CRP), and indexes of non-alcoholic fatty liver disease (NAFLD) in 90 healthy individuals with suboptimal cholesterol levels. Participants were randomly allocated to treatment with a pill of either active treatment or placebo. After 6 weeks, the active-treated group experienced significant improvements in levels of triglycerides (TG), apolipoprotein B-100 (Apo B-100), and apolipoprotein AI (Apo AI) versus baseline. Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), non-high density lipoprotein cholesterol (Non-HDL-C), and hs-CRP also significantly decreased in the active-treated group compared to both baseline and placebo. At the 12-week follow-up, individuals allocated to the combined nutraceutical experienced a significant improvement in TC, LDL-C, Non-HDL-C, TG, Apo B-100, Apo AI, glucose, alanine transaminase (ALT), gamma-glutamyl transferase (gGT), hs-CRP, several indexes of NAFLD, and brachial pulse volume (PV) in comparison with baseline. Improvements in TC, LDL-C, Non-HDL-C, TG, fatty liver index (FLI), hs-CRP, and endothelial reactivity were also detected compared to placebo (p < 0.05 for all). Overall, these findings support the use of the tested dietary supplement containing dry extracts of bergamot and artichoke as a safe and effective approach for the prevention and management of a broad spectrum of cardiometabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cynara scolymusDietary SupplementsPlant ExtractsNon-alcoholic Fatty Liver DiseaseCholesterolHumansMaleFemaleDouble-Blind MethodMiddle AgedAdultC-Reactive ProteinInsulin ResistanceTriglycerides

Stichwörter der Autor:innen

artichokebergamotcholesteroldietary supplementnutraceutical compound

Substanzen

Plant ExtractsCholesterolC-Reactive ProteinTriglycerides

Autor:innen und Institutionen

  • Hypertension and Cardiovascular Risk Research Group, Medical and Surgical Sciences Department, Sant'Orsola-Malpighi University Hospital, 40138 Bologna, Italy.
  • Italian Nutraceutical Society (SINut), 40138 Bologna, Italy.
  • Cardiovascular Medicine Uniti, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

ORCID-Profile: Federica Fogacci, Marina Giovannini, Giulia Fiorini, Claudio Borghi, Arrigo F G Cicero

Förderung

  • Meda Pharma S.p.A. (Monza, MB, Italy)

Zitieren

APA

Fogacci, F., Giovannini, M., Di Micoli, A., Fiorini, G., Grandi, E., Borghi, C., & Cicero, A. F. G. (2024). A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels. Nutrients, 16(11), 1587. https://doi.org/10.3390/nu16111587

Vancouver

Fogacci F, Giovannini M, Di Micoli A, Fiorini G, Grandi E, Borghi C, et al. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels. Nutrients. 2024;16(11):1587. doi:10.3390/nu16111587

BibTeX
@article{Fogacci2024,
  author = {Fogacci, Federica and Giovannini, Marina and Di Micoli, Antonio and Fiorini, Giulia and Grandi, Elisa and Borghi, Claudio and Cicero, Arrigo F G},
  title = {A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors in Individuals with Suboptimal Cholesterol Levels},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {1587},
  doi = {10.3390/nu16111587}
}
Kostenlos starten →